These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37734479)

  • 1. Benvitimod Inhibits IL-4- and IL-13-Induced Tight Junction Impairment by Activating AHR/ARNT Pathway and Inhibiting STAT6 Phosphorylation in Human Keratinocytes.
    Wang X; Mao D; Jia J; Zhang J
    J Invest Dermatol; 2024 Mar; 144(3):509-519.e7. PubMed ID: 37734479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.
    Furue M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites.
    Bao L; Alexander JB; Shi VY; Mohan GC; Chan LS
    Immunology; 2014 Dec; 143(4):601-8. PubMed ID: 24943510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33 down-regulates CLDN1 expression through the ERK/STAT3 pathway in keratinocytes.
    Ryu WI; Lee H; Bae HC; Jeon J; Ryu HJ; Kim J; Kim JH; Son JW; Kim J; Imai Y; Yamanishi K; Jeong SH; Son SW
    J Dermatol Sci; 2018 Jun; 90(3):313-322. PubMed ID: 29534857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benvitimod inhibits MCM6-meditated proliferation of keratinocytes by regulating the JAK/STAT3 pathway.
    Cai Z; Zeng Y; Shi X; Zhang X; Zhu H; Wang W
    J Dermatol Sci; 2023 Feb; 109(2):71-79. PubMed ID: 36774328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis.
    Vu YH; Hashimoto-Hachiya A; Takemura M; Yumine A; Mitamura Y; Nakahara T; Furue M; Tsuji G
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis.
    Bao L; Shi VY; Chan LS
    Mol Immunol; 2012 Feb; 50(1-2):91-7. PubMed ID: 22226123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benvitimod upregulates filaggrin, involucrin and loricrin expressions via aryl hydrocarbon receptor-OVO-like 1 axis.
    Jia Q; Liu P; Wang X; Hu J; Jia J; Zhang J; Li H
    Arch Dermatol Res; 2024 Aug; 316(8):585. PubMed ID: 39207509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.
    Kamsteeg M; Bergers M; de Boer R; Zeeuwen PL; Hato SV; Schalkwijk J; Tjabringa GS
    Am J Pathol; 2011 May; 178(5):2091-9. PubMed ID: 21514424
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    De La Cruz NC; Möckel M; Niehues H; Rübsam M; Malter W; Zinser M; Krummenacher C; Knebel-Mörsdorf D
    J Virol; 2023 Jun; 97(6):e0026223. PubMed ID: 37289055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-4 Downregulation of Involucrin Expression in Human Epidermal Keratinocytes Involves Stat6 Sequestration of the Coactivator CREB-Binding Protein.
    Bao L; Alexander JB; Zhang H; Shen K; Chan LS
    J Interferon Cytokine Res; 2016 Jun; 36(6):374-81. PubMed ID: 26918372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective role of Galectin-7 for skin barrier impairment in atopic dermatitis.
    Umayahara T; Shimauchi T; Iwasaki M; Sakabe JI; Aoshima M; Nakazawa S; Yatagai T; Yamaguchi H; Phadungsaksawasdi P; Kurihara K; Tokura Y
    Clin Exp Allergy; 2020 Aug; 50(8):922-931. PubMed ID: 32474952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor and IL-13 signaling crosstalk in human keratinocytes and atopic dermatitis.
    Proper SP; Dwyer AT; Appiagyei A; Felton JM; Ben-Baruch Morgenstern N; Marlman JM; Kotliar M; Barski A; Troutman TD; Rothenberg ME; Mersha TB; Azouz NP
    Front Allergy; 2024; 5():1323405. PubMed ID: 38344408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro assessment of IL-4- or IL-13-mediated changes in the structural components of keratinocytes in mice and humans.
    Omori-Miyake M; Yamashita M; Tsunemi Y; Kawashima M; Yagi J
    J Invest Dermatol; 2014 May; 134(5):1342-1350. PubMed ID: 24280725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperine Ameliorates Trimellitic Anhydride-Induced Atopic Dermatitis-Like Symptoms by Suppressing Th2-Mediated Immune Responses via Inhibition of STAT6 Phosphorylation.
    Choi DW; Jung SY; Shon DH; Shin HS
    Molecules; 2020 May; 25(9):. PubMed ID: 32392825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation.
    Mitamura Y; Nunomura S; Nanri Y; Ogawa M; Yoshihara T; Masuoka M; Tsuji G; Nakahara T; Hashimoto-Hachiya A; Conway SJ; Furue M; Izuhara K
    Allergy; 2018 Sep; 73(9):1881-1891. PubMed ID: 29528494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis.
    Lee J; Song KM; Jung CH
    Phytomedicine; 2021 Jan; 81():153418. PubMed ID: 33302042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear IL-33 Plays an Important Role in the Suppression of FLG, LOR, Keratin 1, and Keratin 10 by IL-4 and IL-13 in Human Keratinocytes.
    Dai X; Utsunomiya R; Shiraishi K; Mori H; Muto J; Murakami M; Sayama K
    J Invest Dermatol; 2021 Nov; 141(11):2646-2655.e6. PubMed ID: 33865911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling.
    Park Y; Srigouri H; Kim D
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Compounds Tapinarof and
    Tsuji G; Hashimoto-Hachiya A; Matsuda-Taniguchi T; Takai-Yumine A; Takemura M; Yan X; Furue M; Nakahara T
    Front Immunol; 2022; 13():745997. PubMed ID: 35663970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.